Zedan Zhang

819 total citations
34 papers, 520 citations indexed

About

Zedan Zhang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Zedan Zhang has authored 34 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Zedan Zhang's work include Renal cell carcinoma treatment (8 papers), Ferroptosis and cancer prognosis (7 papers) and Epigenetics and DNA Methylation (6 papers). Zedan Zhang is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Ferroptosis and cancer prognosis (7 papers) and Epigenetics and DNA Methylation (6 papers). Zedan Zhang collaborates with scholars based in China, Poland and Russia. Zedan Zhang's co-authors include Hongkai Zhuang, Yuming Yu, Jiumin Liu, Xudong Tang, Fengyun Wang, Lin Xu, Jingcheng Zhou, Yanqing Gong, Wuping Yang and Kenan Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Zedan Zhang

32 papers receiving 517 citations

Peers

Zedan Zhang

PRM

ONCOL

IMMUN

Xiangming Mao China

Chuangyan Wu China

Guanghui Wang China

Haiying Wang China

Mingtian Wei China

Yongchang Lai China

Jiancong Hu China

Yunchang Yuan China

Shuchen Lin China

Gustaw Lech Poland

Xiangming Mao China

Zedan Zhang

310 ×1.1

138 ×0.8

PRM

207 ×1.3

96 ×1.1

ONCOL

47 ×0.6

IMMUN

Citations per year, relative to Zedan Zhang Zedan Zhang (= 1×) peers Xiangming Mao

Countries citing papers authored by Zedan Zhang

Since Specialization

Citations

This map shows the geographic impact of Zedan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zedan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zedan Zhang more than expected).

Fields of papers citing papers by Zedan Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zedan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zedan Zhang. The network helps show where Zedan Zhang may publish in the future.

Co-authorship network of co-authors of Zedan Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Zedan Zhang. A scholar is included among the top collaborators of Zedan Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zedan Zhang. Zedan Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Zedan, Yi Wang, Wuping Yang, et al.. (2024). Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort. iScience. 27(7). 110357–110357.

Zhuang, Hongkai, Zedan Zhang, Xinming Chen, et al.. (2024). A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma. Cellular Oncology. 47(4). 1205–1220. 2 indexed citations

Zhao, Ran, Weili Wang, Wen Zhang, et al.. (2024). Effects of genetically proxied statins on diabetic nephropathy and retinopathy: a Mendelian randomization study. Scientific Reports. 14(1). 16885–16885. 5 indexed citations

Yang, Wuping, Zedan Zhang, Lei Li, et al.. (2023). ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation. Cell Death and Disease. 14(3). 212–212. 9 indexed citations

Xu, Yawei, Wuping Yang, Zedan Zhang, et al.. (2023). Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC. Molecular Diagnosis & Therapy. 27(6). 741–752. 1 indexed citations

Zhang, Kenan, Wuping Yang, Zedan Zhang, et al.. (2022). A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma. Journal of Oncology. 2022. 1–19. 4 indexed citations

Zhang, Zedan, Wuping Yang, Yawei Xu, et al.. (2022). Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma. Journal of Immunology Research. 2022. 1–19. 8 indexed citations

Zhang, Kenan, Wuping Yang, Kaifang Ma, et al.. (2022). Genotype–phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions. Journal of Medical Genetics. 60(5). 477–483.

Xu, Yawei, Jingcheng Zhou, Lei Li, et al.. (2022). FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability. International Journal of Biological Sciences. 18(15). 5943–5962. 60 indexed citations

10.

Yang, Wuping, Jingcheng Zhou, Zedan Zhang, et al.. (2022). Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma. International Journal of Biological Sciences. 18(6). 2583–2596. 10 indexed citations

11.

Xu, Lin, Jiaqi Zhang, Yifan Wang, et al.. (2021). Uncovering the mechanism of Ge-Gen-Qin-Lian decoction for treating ulcerative colitis based on network pharmacology and molecular docking verification. Bioscience Reports. 41(2). 31 indexed citations

12.

Zhang, Zedan, et al.. (2021). IL-21 Prevents Expansion of CD8+CD28− T Cells Stimulated by IL-15 and Changes Their Subset Distribution. Transplantation Proceedings. 53(7). 2407–2414. 1 indexed citations

13.

Zhang, Zedan, Yanjun Liu, Hongkai Zhuang, et al.. (2021). A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma. Journal of Immunology Research. 2021. 1–37. 12 indexed citations

14.

Liu, Xuechao, et al.. (2021). Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma. Frontiers in Immunology. 12. 653358–653358. 29 indexed citations

15.

Zhuang, Hongkai, Shujie Wang, Bo Chen, et al.. (2021). Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Frontiers in Immunology. 12. 790661–790661. 15 indexed citations

16.

Zhang, Zedan, et al.. (2020). [Systematic review and Meta-analysis of efficacy and safety of Xiangsha Yangwei Pills in treatment of chronic gastritis].. PubMed. 45(11). 2668–2676. 3 indexed citations

17.

Zhang, Zedan, et al.. (2020). Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft. Journal of Immunology Research. 2020(1). 2415374–2415374. 12 indexed citations

18.

Zhuang, Hongkai, Shanzhou� Huang, Zixuan Zhou, et al.. (2020). A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer. Cancer Cell International. 20(1). 493–493. 15 indexed citations

19.

Zhang, Zedan, et al.. (2020). Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma. Cancer Cell International. 20(1). 27–27. 102 indexed citations

20.

Shen, Suxing, Jing Li, Qi Guo, et al.. (2015). Body Mass Index Is Associated with Physical Performance in Suburb-Dwelling Older Chinese: A Cross-Sectional Study. PLoS ONE. 10(3). e0119914–e0119914. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact